Yulin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yulin Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bing Wang
Department of Radiology, Peking University Shenzhen Hospital , Shenzhen 518000, China
1 shared publication Chenya Feng
Department of Radiology, Nan fang Hospital, Southern Medical University , Guangzhou 510515, China
1 shared publication- Fajun Nan
Shanghai Institute of Materia Medica
1 shared publication - Guanxun Cheng
Department of Radiology, Peking University Shenzhen Hospital
1 shared publication - Lijun Liu
Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada
1 shared publication Tongshuang Li
Department of Chemistry, Hebei University, Baoding 071 002, People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 3 February 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1156) , 779-786
The CT and MRI features of benign calvarium and skull base osteoblastoma
Objective: We retrospectively reviewed the CT and MRI features of patients with benign osteoblastoma in the calvarium and skull base (CSBOB). Methods: Nine cases of pathologically confirmed benign CSBOB were analysed retrospectively. The patients had undergone CT and/or MRI. Tumour location, size, and imaging features were reviewed and recorded. Results: The patients included four males and five females with a mean age of 27.0 years (age 14-40 years). The tumours were located in the frontal bone in 3 patients, the occipital bone in 3 patients, and in the parietal bone, sphenoid bone, and skull base in 1 patient each. On CT, the tumours measured 5.1 ± 3.3 (1.8-8.4) cm. Seven tumours were shown to have caused expansile bony destruction with an eggshell appearance and varying degrees of calcification or matrix mineralization. Multiple septa were observed in 5 tumours. Intracranial growth was observed in 5 tumours. On MRI, 7 tumours showed heterogeneous hypo- to isointensity on T1WI. Heterogeneous high signal patterns with low signal rims and septa were observed in 6 tumours on T2WI, and 4 showed a fluid-fluid level. On contrast-enhanced imaging, 6 tumours showed peripheral and septal enhancement, and 2 showed the dural tail sign. Conclusions: Benign CSBOB is a rare tumour characterized by expansile bony destruction, septa, a sclerotic rim and calcification or matrix mineralization on CT and MRI. Advances in knowledge: The findings from this study contribute to a better understanding of benign CSBOB and provide valuable imaging features that can aid in its diagnosis and differentiation from other tumours in the calvarium and skull base.
- 3 February 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1156) , 779-786
Open AccessThe CT and MRI features of benign calvarium and skull base osteoblastoma
Objective: We retrospectively reviewed the CT and MRI features of patients with benign osteoblastoma in the calvarium and skull base (CSBOB). Methods: Nine cases of pathologically confirmed benign CSBOB were analysed retrospectively. The patients had undergone CT and/or MRI. Tumour location, size, and imaging features were reviewed and recorded. Results: The patients included four males and five females with a mean age of 27.0 years (age 14-40 years). The tumours were located in the frontal bone in 3 patients, the occipital bone in 3 patients, and in the parietal bone, sphenoid bone, and skull base in 1 patient each. On CT, the tumours measured 5.1 ± 3.3 (1.8-8.4) cm. Seven tumours were shown to have caused expansile bony destruction with an eggshell appearance and varying degrees of calcification or matrix mineralization. Multiple septa were observed in 5 tumours. Intracranial growth was observed in 5 tumours. On MRI, 7 tumours showed heterogeneous hypo- to isointensity on T1WI. Heterogeneous high signal patterns with low signal rims and septa were observed in 6 tumours on T2WI, and 4 showed a fluid-fluid level. On contrast-enhanced imaging, 6 tumours showed peripheral and septal enhancement, and 2 showed the dural tail sign. Conclusions: Benign CSBOB is a rare tumour characterized by expansile bony destruction, septa, a sclerotic rim and calcification or matrix mineralization on CT and MRI. Advances in knowledge: The findings from this study contribute to a better understanding of benign CSBOB and provide valuable imaging features that can aid in its diagnosis and differentiation from other tumours in the calvarium and skull base.
- 1 August 1998
- Published by Taylor & Francis in Synthetic Communications
- Vol. 28 (15) , 2861-2869
First Total Synthesis of (±)-Kenusanone B
The first total synthesis of a natural prenylflavanone, (±)-kenusanone B (1) has been achieved by condensation of acetophenone 4 and benzaldehyde 6 followed by cyclization and deprotection. Chloromethyl methyl ether was used as a facile protecting reagent of free hydroxy groups for the synthesis of polyhydroxylated flavanones.
- 1 August 1998
- Published by Taylor & Francis in Synthetic Communications
- Vol. 28 (15) , 2861-2869
First Total Synthesis of (±)-Kenusanone B
The first total synthesis of a natural prenylflavanone, (±)-kenusanone B (1) has been achieved by condensation of acetophenone 4 and benzaldehyde 6 followed by cyclization and deprotection. Chloromethyl methyl ether was used as a facile protecting reagent of free hydroxy groups for the synthesis of polyhydroxylated flavanones.
- 1 January 1997
- Published by Institute of Organic Chemistry & Biochemistry in Collection of Czechoslovak Chemical Communications
- Vol. 62 (7) , 1089-1094
Synthesis of 2α,3α-Epoxy-9β-benzoyloxy-β-agarofuran and 2,3-Dehydro-4β,12-epoxy-9β-benzoyloxy-β-dihydroagarofuran
The first stereoselective synthesis of 2α,3α-epoxy-9β-benzoyloxy-β-agarofuran (3) and 2,3-dehydro-4β,12-epoxy-9β-benzoyloxy-β-dihydroagarofuran (4) from (-)-carvone in 13 steps, respectively, has been described. In addition, the synthesis of 2,3-dehydro-4β,9β-dihydroxy-β-dihydroagarofuran (13) has also been reported. By the reduction of 4 to give 13, the 4β,12-epoxy configuration of 4 was established.
- 1 January 1997
- Published by Institute of Organic Chemistry & Biochemistry in Collection of Czechoslovak Chemical Communications
- Vol. 62 (7) , 1089-1094
Synthesis of 2α,3α-Epoxy-9β-benzoyloxy-β-agarofuran and 2,3-Dehydro-4β,12-epoxy-9β-benzoyloxy-β-dihydroagarofuran
The first stereoselective synthesis of 2α,3α-epoxy-9β-benzoyloxy-β-agarofuran (3) and 2,3-dehydro-4β,12-epoxy-9β-benzoyloxy-β-dihydroagarofuran (4) from (-)-carvone in 13 steps, respectively, has been described. In addition, the synthesis of 2,3-dehydro-4β,9β-dihydroxy-β-dihydroagarofuran (13) has also been reported. By the reduction of 4 to give 13, the 4β,12-epoxy configuration of 4 was established.